Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
J Dev Orig Health Dis ; 10(3): 353-361, 2019 06.
Article in English | MEDLINE | ID: mdl-30968813

ABSTRACT

The soluble fms-like tyrosine kinase factor 1 (sFlt-1) is a major contributor to antiangiogenesis during preeclampsia. However, little is known about the effects of sFlt-1 on fetal health. In this study we aim to evaluate the effects of the sFlt-1 concentration during pregnancy on fetal liver physiology. We used adenoviral gene delivery in Sprague-Dawley dams (seven females, 10 weeks old) during mid-gestation (gestational day 8) with adenovirus overexpressing sFlt-1, and age-matched controls (six females, 10 weeks old) with empty adenoviral virus in order to quantify the sFlt-1 concentrations in pregnant dams. Dams exposed to adenoviral sFlt-1 delivery were subdivided into a low (n=4) and high sFlt-1 (n=3) group based on host response to the virus. One-way analysis of variance showed that fetuses (five per dam) exposed to high sFlt-1 concentrations in utero show fetal growth restriction (1.84±0.043 g high sFlt-1 v. 2.32±0.036 g control; mean (M)±s.e.m.; P<0.001), without hypertension or proteinuria in the dams. In continuation, the microarray analysis of the fetal liver of the high sFlt-1 group showed significant enrichment of key genes for fatty acid metabolism and Ppara targets. In addition, using pyrosequencing, we found that the Ppara enrichment in the high sFlt-1 group is accompanied by decreased methylation of its promoter (1.89±0.097 mean % methylation in high sFlt-1 v. 2.26±0.095 mean % methylation in control, M±s.e.m., P<0.02). Our data show that high sFlt-1 concentrations during pregnancy have detrimental effects on the fatty acid metabolism genes and the Ppara targets in the fetal liver.


Subject(s)
Fetal Growth Retardation/metabolism , Fetus/metabolism , Gene Expression Regulation , Liver/metabolism , Prenatal Exposure Delayed Effects/metabolism , Vascular Endothelial Growth Factor Receptor-1/adverse effects , Animals , Female , Fetal Growth Retardation/etiology , Fetal Growth Retardation/pathology , Fetus/pathology , Gene Expression Profiling , Liver/pathology , Male , Pregnancy , Prenatal Exposure Delayed Effects/etiology , Prenatal Exposure Delayed Effects/pathology , Rats , Rats, Sprague-Dawley
2.
Int J Obes (Lond) ; 41(5): 722-728, 2017 05.
Article in English | MEDLINE | ID: mdl-28179648

ABSTRACT

BACKGROUND/OBJECTIVES: Although adipose tissue (AT) hypoxia is present in rodent models of obesity, evidence for this in humans is limited. Here, we investigated the effects of diet-induced weight loss (WL) on abdominal subcutaneous AT oxygen tension (pO2), AT blood flow (ATBF), AT capillary density, AT morphology and transcriptome, systemic inflammatory markers and insulin sensitivity in humans. SUBJECTS/METHODS: Fifteen overweight and obese individuals underwent a dietary intervention (DI), consisting of a 5-week very-low-calorie diet (VLCD, 500 kcal day-1; WL), and a subsequent 4-week weight stable diet (WS). Body composition, AT pO2 (optochemical monitoring), ATBF (133Xe washout), and whole-body insulin sensitivity were determined, and AT biopsies were collected at baseline, end of WL (week 5) and end of WS (week 9). RESULTS: Body weight, body fat percentage and adipocyte size decreased significantly during the DI period. The DI markedly decreased AT pO2 and improved insulin sensitivity, but did not alter ATBF. Finally, the DI increased AT gene expression of pathways related to mitochondrial biogenesis and non-mitochondrial oxygen consumption. CONCLUSIONS: VLCD-induced WL markedly decreases abdominal subcutaneous AT pO2, which is paralleled by a reduction in adipocyte size, increased AT gene expression of mitochondrial biogenesis markers and non-mitochondrial oxygen consumption pathways, and improved whole-body insulin sensitivity in humans.


Subject(s)
Inflammation/physiopathology , Insulin Resistance/physiology , Insulin/metabolism , Obesity/physiopathology , Overweight/physiopathology , Oxygen/metabolism , Subcutaneous Fat, Abdominal/metabolism , Weight Loss/physiology , Adipocytes/physiology , Cell Hypoxia/physiology , Diet, Reducing , Female , Gene Expression Regulation , Humans , Inflammation/diet therapy , Inflammation/metabolism , Male , Middle Aged , Obesity/diet therapy , Obesity/metabolism , Overweight/diet therapy , Overweight/metabolism , Oxygen Consumption , Phenotype , Treatment Outcome
3.
Int J Obes (Lond) ; 41(2): 309-316, 2017 02.
Article in English | MEDLINE | ID: mdl-27840413

ABSTRACT

BACKGROUND/OBJECTIVES: Moderate weight loss (WL) can ameliorate adverse health effects associated with obesity, reflected by an improved adipose tissue (AT) gene expression profile. However, the effect of rate of WL on the AT transcriptome is unknown. We investigated the global AT gene expression profile before and after two different rates of WL that resulted in similar total WL, and after a subsequent weight stabilization period. SUBJECTS/METHODS: In this randomized controlled trial, 25 male and 28 female individuals (body mass index (BMI): 28-35 kg m-2) followed either a low-calorie diet (LCD; 1250 kcal day-1) for 12 weeks or a very-low-calorie diet (VLCD; 500 kcal day-1) for 5 weeks (WL period) and a subsequent weight stable (WS) period of 4 weeks. The WL period and WS period together is termed dietary intervention (DI) period. Abdominal subcutaneous AT biopsies were collected for microarray analysis and gene expression changes were calculated for all three periods in the LCD group, VLCD group and between diets (ΔVLCD-ΔLCD). RESULTS: WL was similar between groups during the WL period (LCD: -8.1±0.5 kg, VLCD: -8.9±0.4 kg, difference P=0.25). Overall, more genes were significantly regulated and changes in gene expression appeared more pronounced in the VLCD group compared with the LCD group. Gene sets related to mitochondrial function, adipogenesis and immunity/inflammation were more strongly upregulated on a VLCD compared with a LCD during the DI period (positive ΔVLCD-ΔLCD). Neuronal and olfactory-related gene sets were decreased during the WL period and DI period in the VLCD group. CONCLUSIONS: The rate of WL (LCD vs VLCD), with similar total WL, strongly regulates AT gene expression. Increased mitochondrial function, angiogenesis and adipogenesis on a VLCD compared with a LCD reflect potential beneficial diet-induced changes in AT, whereas differential neuronal and olfactory regulation suggest functions of these genes beyond the current paradigm.


Subject(s)
Adipocytes/metabolism , Gene Expression Regulation , Obesity/genetics , Obesity/physiopathology , Overweight/genetics , Overweight/physiopathology , Subcutaneous Fat, Abdominal/metabolism , Weight Loss/genetics , Adipogenesis , Caloric Restriction , Diet, Reducing , Extracellular Matrix/metabolism , Female , Humans , Male , Middle Aged , Tissue Array Analysis , Weight Loss/physiology
4.
BMC Neurosci ; 17(1): 26, 2016 05 20.
Article in English | MEDLINE | ID: mdl-27207102

ABSTRACT

BACKGROUND: Anorexia can occur as a serious complication of disease. Increasing evidence suggests that inflammation plays a major role, along with a hypothalamic dysregulation characterized by locally elevated serotonin levels. The present study was undertaken to further explore the connections between peripheral inflammation, anorexia and hypothalamic serotonin metabolism and signaling pathways. First, we investigated the response of two hypothalamic neuronal cell lines to TNFα, IL-6 and LPS. Next, we studied transcriptomic changes and serotonergic activity in the hypothalamus of mice after intraperitoneal injection with TNFα, IL-6 or a combination of TNFα and IL-6. RESULTS: In vitro, we showed that hypothalamic neurons responded to inflammatory mediators by releasing cytokines. This inflammatory response was associated with an increased serotonin release. Mice injected with TNFα and IL-6 showed decreased food intake, associated with altered expression of inflammation-related genes in the hypothalamus. In addition, hypothalamic serotonin turnover showed to be elevated in treated mice. CONCLUSIONS: Overall, our results underline that peripheral inflammation reaches the hypothalamus where it affects hypothalamic serotoninergic metabolism. These hypothalamic changes in serotonin pathways are associated with decreased food intake, providing evidence for a role of serotonin in inflammation-induced anorexia.


Subject(s)
Anorexia/etiology , Anorexia/metabolism , Hypothalamus/metabolism , Inflammation/complications , Inflammation/metabolism , Serotonin/metabolism , Animals , Cell Line , Cytokines/metabolism , Disease Models, Animal , Eating/physiology , Gene Expression Profiling , Hydroxyindoleacetic Acid/metabolism , Interleukin-6 , Lipopolysaccharides , Male , Mice, Inbred C57BL , Neurons/metabolism , Transcriptome , Tumor Necrosis Factor-alpha
5.
Int J Obes (Lond) ; 38(3): 470-3, 2014 Mar.
Article in English | MEDLINE | ID: mdl-23958793

ABSTRACT

Polyphenolic compounds, such as resveratrol, have recently received widespread interest because of their ability to mimic effects of calorie restriction. The objective of the present study was to gain more insight into the effects of 30 days resveratrol supplementation on adipose tissue morphology and underlying processes. Eleven healthy obese men were supplemented with placebo and resveratrol for 30 days (150 mg per day), separated by a 4-week washout period in a double-blind randomized crossover design. A postprandial abdominal subcutaneous adipose tissue biopsy was collected to assess adipose tissue morphology and gene expression using microarray analysis. Resveratrol significantly decreased adipocyte size, with a shift toward a reduction in the proportion of large and very-large adipocytes and an increase in small adipocytes. Microarray analysis revealed downregulation of Wnt and Notch signaling pathways and upregulation of pathways involved in cell cycle regulation after resveratrol supplementation, suggesting enhanced adipogenesis. Furthermore, lysosomal/phagosomal pathway and transcription factor EB were upregulated reflecting an alternative pathway of lipid breakdown by autophagy. Further research is necessary to investigate whether resveratrol improves adipose tissue function.


Subject(s)
Adipocytes/drug effects , Adipocytes/metabolism , Adipose Tissue/metabolism , Enzyme Inhibitors/therapeutic use , Obesity/drug therapy , Stilbenes/therapeutic use , Adipogenesis/drug effects , Adipose Tissue/drug effects , Adult , Aged , Cross-Over Studies , Double-Blind Method , Gene Expression Profiling , Humans , Male , Middle Aged , Obesity/genetics , Obesity/metabolism , Receptors, Notch/drug effects , Receptors, Notch/metabolism , Resveratrol , Signal Transduction/drug effects , Treatment Outcome , Wnt Signaling Pathway/drug effects
6.
Cell Death Differ ; 20(11): 1580-92, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23933814

ABSTRACT

Death receptor-mediated hepatocyte apoptosis is implicated in a wide range of liver diseases including viral and alcoholic hepatitis, ischemia/reperfusion injury, fulminant hepatic failure, cholestatic liver injury, as well as cancer. Deletion of NF-κB essential modulator in hepatocytes (IKKγ/Nemo) causes spontaneous progression of TNF-mediated chronic hepatitis to hepatocellular carcinoma (HCC). Thus, we analyzed the role of death receptors including TNFR1 and TRAIL in the regulation of cell death and the progression of liver injury in IKKγ/Nemo-deleted livers. We crossed hepatocyte-specific IKKγ/Nemo knockout mice (Nemo(Δhepa)) with constitutive TNFR1(-/-) and TRAIL(-/-) mice. Deletion of TNFR1, but not TRAIL, decreased apoptotic cell death, compensatory proliferation, liver fibrogenesis, infiltration of immune cells as well as pro-inflammatory cytokines, and indicators of tumor growth during the progression of chronic liver injury. These events were associated with diminished JNK activation. In contrast, deletion of TNFR1 in bone-marrow-derived cells promoted chronic liver injury. Our data demonstrate that TNF- and not TRAIL signaling determines the progression of IKKγ/Nemo-dependent chronic hepatitis. Additionally, we show that TNFR1 in hepatocytes and immune cells have different roles in chronic liver injury-a finding that has direct implications for treating chronic liver disease.


Subject(s)
I-kappa B Kinase/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Lung Injury/metabolism , Receptors, Tumor Necrosis Factor, Type I/metabolism , Animals , Disease Progression , I-kappa B Kinase/genetics , Intracellular Signaling Peptides and Proteins/genetics , Lung Injury/enzymology , Lung Injury/genetics , Lung Injury/pathology , Male , Mice , Mice, Knockout , Mice, Transgenic , Models, Genetic , Receptors, Tumor Necrosis Factor, Type I/genetics , Signal Transduction
7.
J Lipid Res ; 51(8): 2090-104, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20363834

ABSTRACT

The aim of the present study was to examine whether pretreatment with different fatty acids, as well as the liver X receptor (LXR) agonist T0901317, could modify metabolic switching of human myotubes. The n-3 FA eicosapentaenoic acid (EPA) increased suppressibility, the ability of glucose to suppress FA oxidation. Substrate-regulated flexibility, the ability to increase FA oxidation when changing from a high glucose, low fatty acid condition ("fed") to a high fatty acid, low glucose ("fasted") condition, was increased by EPA and other n-3 FAs. Adaptability, the capacity to increase FA oxidation with increasing FA availability, was enhanced after pretreatment with EPA, linoleic acid (LA), and palmitic acid (PA). T0901317 counteracted the effect of EPA on suppressibility and adaptability, but it did not affect these parameters alone. EPA per se accumulated less, however, EPA, LA, oleic acid, and T0901317 treatment increased the number of lipid droplets (LD) in myotubes. LD volume and intensity, as well as mitochondrial mass, were independent of FA pretreatment. Microarray analysis showed that EPA regulated more genes than the other FAs and that specific pathways involved in carbohydrate metabolism were induced only by EPA. The present study suggests a favorable effect of n-3 FAs on skeletal muscle metabolic switching and glucose utilization.


Subject(s)
Fatty Acids, Omega-3/pharmacology , Muscle Fibers, Skeletal/drug effects , Muscle Fibers, Skeletal/metabolism , Biological Transport/drug effects , Energy Metabolism/drug effects , Fatty Acids, Omega-3/metabolism , Female , Gene Expression Profiling , Glucose/metabolism , Humans , Hydrocarbons, Fluorinated/pharmacology , Insulin/pharmacology , Liver X Receptors , Male , Middle Aged , Muscle Fibers, Skeletal/cytology , Oleic Acid/metabolism , Orphan Nuclear Receptors/agonists , Orphan Nuclear Receptors/metabolism , Oxidation-Reduction/drug effects , Signal Transduction/drug effects , Sulfonamides/pharmacology
8.
Drug Metab Dispos ; 38(4): 635-40, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20047988

ABSTRACT

Cafestol is a diterpene present in unfiltered coffees. It is the most potent cholesterol-elevating compound present in the human diet. However, the precise mechanisms underlying this effect are still unclear. In contrast, cafestol is also known as a hepatoprotective compound, which is likely to be related to the induction of glutathione biosynthesis and conjugation. In the present study, we investigated whole-body distribution, biliary excretion, and portal bioavailability of cafestol in mice. First, dissection was used to study distribution. Five hours after an oral dose with (3)H-labeled cafestol, most activity was found in small intestine, liver, and bile. These results were confirmed by quantitative whole-body autoradiography in a time course study, which also showed elimination of all radioactivity within 48 h after administration. Next, radiolabeled cafestol was dosed intravenously to bile duct-cannulated mice. Five hours after the dose 20% of the radioactivity was found in bile. Bile contained several metabolites but no parent compound. After intestinal administration of radioactive cafestol to portal vein-cannulated mice, cafestol was shown to be rapidly absorbed into the portal vein as the parent compound, a glucuronide, and an unidentified metabolite. From the presence of a glucuronide in bile that can be deconjugated by a bacterial enzyme and the prolonged absorption of parent compound from the gastrointestinal tract, we hypothesized that cafestol undergoes enterohepatic cycling. Together with our earlier observation that epoxidation of the furan ring occurs in liver, these findings merit further research on the process of accumulation of this coffee ingredient in liver and intestinal tract.


Subject(s)
Cholesterol/blood , Coffee/chemistry , Diterpenes/pharmacokinetics , Animals , Autoradiography , Bile/metabolism , Chromatography, High Pressure Liquid , Epoxy Compounds/metabolism , Gallbladder/metabolism , Glucuronides/metabolism , Intestinal Absorption/physiology , Male , Mice , Mice, Inbred C57BL , Tissue Distribution
9.
Am J Physiol Endocrinol Metab ; 298(3): E602-13, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19996385

ABSTRACT

Liver X receptors (LXRs) are important regulators of cholesterol, lipid, and glucose metabolism and have been extensively studied in liver, macrophages, and adipose tissue. However, their role in skeletal muscle is poorly studied and the functional role of each of the LXRalpha and LXRbeta subtypes in skeletal muscle is at present unknown. To study the importance of each of the receptor subtypes, myotube cultures derived from wild-type (WT) and LXRalpha and LXRbeta knockout (KO) mice were established. The present study showed that treatment with the LXR agonist T0901317 increased lipogenesis and apoA1-dependent cholesterol efflux in LXRalpha KO and WT myotubes but not in LXRbeta KO cells. The functional studies were confirmed by T0901317-induced increase in mRNA levels of LXR target genes involved in lipid and cholesterol metabolism in myotubes established from WT and LXRalpha KO mice, whereas only minor changes were observed for these genes in myotubes from LXRbeta KO mice. Gene expression analysis using microarrays showed that very few genes other than the classical, well-known LXR target genes were regulated by LXR in skeletal muscle. The present study also showed that basal glucose uptake was increased in LXRbeta KO myotubes compared with WT myotubes, suggesting a role for LXRbeta in glucose metabolism in skeletal muscle. In conclusion, LXRbeta seems to be the main LXR subtype regulating lipogenesis and cholesterol efflux in skeletal muscle.


Subject(s)
Cholesterol/metabolism , Lipid Metabolism/genetics , Lipogenesis/physiology , Muscle, Skeletal/metabolism , Myoblasts/physiology , Orphan Nuclear Receptors/metabolism , Animals , Cells, Cultured , Feedback, Physiological/physiology , Liver X Receptors , Mice , Mice, Knockout , Muscle, Skeletal/cytology
10.
Eur J Clin Nutr ; 63(1): 2-10, 2009 Jan.
Article in English | MEDLINE | ID: mdl-17928804

ABSTRACT

BACKGROUND: Nutrition science aims to create new knowledge, but scientists rarely sit back to reflect on what nutrition research has achieved in recent decades. METHODS: We report the outcome of a 1-day symposium at which the audience was asked to vote on the greatest discoveries in nutrition since 1976 and on the greatest challenges for the coming 30 years. Most of the 128 participants were Dutch scientists working in nutrition or related biomedical and public health fields. Candidate discoveries and challenges were nominated by five invited speakers and by members of the audience. Ballot forms were then prepared on which participants selected one discovery and one challenge. RESULTS: A total of 15 discoveries and 14 challenges were nominated. The audience elected Folic acid prevents birth defects as the greatest discovery in nutrition science since 1976. Controlling obesity and insulin resistance through activity and diet was elected as the greatest challenge for the coming 30 years. This selection was probably biased by the interests and knowledge of the speakers and the audience. For the present review, we therefore added 12 discoveries from the period 1976 to 2006 that we judged worthy of consideration, but that had not been nominated at the meeting. CONCLUSIONS: The meeting did not represent an objective selection process, but it did demonstrate that the past 30 years have yielded major new discoveries in nutrition and health.


Subject(s)
Nutritional Physiological Phenomena , Nutritional Sciences/history , Biomedical Research/history , History, 20th Century , History, 21st Century , Humans
11.
Ned Tijdschr Geneeskd ; 150(52): 2873-5, 2006 Dec 30.
Article in Dutch | MEDLINE | ID: mdl-17319220

ABSTRACT

OBJECTIVE: To determine the amounts of the serum-cholesterol raising diterpenes cafestol and kahweol in coffee made with coffee pads and the Senseo coffee machine as opposed to filtered and unfiltered coffee. DESIGN: Observational. METHOD: In five cities in the Netherlands coffee was purchased in three major supermarkets resulting in a total of 30 samples of coffee pads. The levels of cafestol and kahweol were determined by gas chromatography. As controls, the diterpene levels in filtered and unfiltered coffee were also measured. RESULTS: Coffee prepared using coffee pads contained on average 0.76 mg/l cafestol (95% CI: 0.69-0.82) and 0.85 mg/l kahweol (95% CI: 0.77-0.94). Filtered coffee contained 0.76 mg/l cafestol (95% CI: 0.63-0.88) and 0.81 mg/l kahweol (95% CI: 0.63-0.99). Unfiltered coffee contained 72.5 mg/l cafestol (95% CI: 48.5-96.4) and 71.5 mg/l kahweol (95% CI: 45.0-98.1). CONCLUSION: Coffee prepared using coffee pads and the Senseo coffee machine contained minute levels of diterpenes comparable to those of filtered coffee. Its effect on serum-cholesterol levels is therefore likely to be negligible.


Subject(s)
Cholesterol/blood , Coffee/chemistry , Diterpenes/analysis , Lipid Metabolism/drug effects , Diterpenes/pharmacology , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...